Optimising asthma care
dc.contributor.author | Irusen E.M. | |
dc.date.accessioned | 2011-05-15T16:17:58Z | |
dc.date.available | 2011-05-15T16:17:58Z | |
dc.date.issued | 2007 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Editorial | |
dc.identifier.citation | South African Family Practice | |
dc.identifier.citation | 49 | |
dc.identifier.citation | 5 | |
dc.identifier.issn | 1726426X | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14451 | |
dc.subject | beta adrenergic receptor stimulating agent | |
dc.subject | corticosteroid | |
dc.subject | leukotriene receptor blocking agent | |
dc.subject | add on therapy | |
dc.subject | asthma | |
dc.subject | bronchodilatation | |
dc.subject | corticosteroid therapy | |
dc.subject | disease control | |
dc.subject | disease exacerbation | |
dc.subject | drug dose increase | |
dc.subject | drug effect | |
dc.subject | editorial | |
dc.subject | human | |
dc.subject | lung capacity | |
dc.subject | lung function | |
dc.subject | patient care | |
dc.subject | patient compliance | |
dc.subject | practice guideline | |
dc.subject | quality of life | |
dc.subject | sleep disorder | |
dc.title | Optimising asthma care | |
dc.type | Editorial |